D.B. Root & Company, LLC Biomarin Pharmaceutical Inc Transaction History

D.B. Root & Company, LLC

$296 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$76.22 - $98.51 $30,106 - $38,911	-395 Reduced 8.97%	4,011 $386,000
Q3 2023 Nov 03, 2023	BUY	$85.07 - $94.48 $2,807 - $3,117	33 Added 0.75%	4,406 $389,000
Q2 2023 Jul 18, 2023	BUY	$86.68 - $100.3 $25,137 - $29,087	290 Added 7.1%	4,373 $379,000
Q1 2023 Apr 18, 2023	BUY	$87.74 - $117.27 $87 - $117	1 Added 0.02%	4,083 $397,000
Q4 2022 Jan 27, 2023	SELL	$80.93 - $108.63 $24,198 - $32,480	-299 Reduced 6.82%	4,082 $0
Q3 2022 Oct 26, 2022	SELL	$82.16 - $96.94 $575 - $678	-7 Reduced 0.16%	4,381 $371,000
Q2 2022 Jul 21, 2022	SELL	$71.48 - $86.85 $230,380 - $279,917	-3,223 Reduced 42.35%	4,388 $363,000
Q1 2022 May 06, 2022	BUY	$74.28 - $92.69 $2,525 - $3,151	34 Added 0.45%	7,611 $586,000
Q4 2021 Feb 01, 2022	SELL	$71.72 - $91.47 $10,901 - $13,903	-152 Reduced 1.97%	7,577 $669,000
Q3 2021 Oct 22, 2021	SELL	$74.77 - $85.47 $113,725 - $129,999	-1,521 Reduced 16.44%	7,729 $597,000
Q2 2021 Jul 28, 2021	SELL	$75.51 - $84.79 $6,191 - $6,952	-82 Reduced 0.88%	9,250 $771,000
Q1 2021 May 04, 2021	BUY	$74.73 - $90.69 $174,569 - $211,851	2,336 Added 33.39%	9,332 $704,000
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $1,887 - $2,345	-26 Reduced 0.37%	6,996 $613,000
Q3 2020 Oct 22, 2020	BUY	$71.87 - $131.03 $56,274 - $102,596	783 Added 12.55%	7,022 $534,000
Q2 2020 Aug 06, 2020	SELL	$79.55 - $124.22 $17,501 - $27,328	-220 Reduced 3.41%	6,239 $769,000
Q1 2020 Apr 29, 2020	BUY	$71.37 - $96.85 $19,626 - $26,633	275 Added 4.45%	6,459 $545,000
Q4 2019 Jan 14, 2020	BUY	$64.27 - $86.37 $145,250 - $195,196	2,260 Added 57.59%	6,184 $522,000
Q3 2019 Oct 29, 2019	SELL	$67.4 - $85.11 $11,795 - $14,894	-175 Reduced 4.27%	3,924 $264,000
Q2 2019 Jul 19, 2019	SELL	$80.35 - $93.9 $3,615 - $4,225	-45 Reduced 1.09%	4,099 $351,000
Q1 2019 Apr 12, 2019	BUY	$84.2 - $98.62 $33,174 - $38,856	394 Added 10.51%	4,144 $368,000
Q4 2018 Jan 25, 2019	SELL	$80.14 - $106.07 $224,392 - $296,996	-2,800 Reduced 42.75%	3,750 $319,000
Q3 2018 Nov 05, 2018	SELL	$93.92 - $105.72 $198,171 - $223,069	-2,110 Reduced 24.36%	6,550 $635,000
Q2 2018 Jul 25, 2018	BUY	$76.01 - $99.03 $26,223 - $34,165	345 Added 4.15%	8,660 $816,000
Q1 2018 May 02, 2018	BUY	$77.67 - $92.63 $645,826 - $770,218	8,315 New	8,315 $674,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on D.B. Root & Company, LLC with notifications on news.

Account